138 related articles for article (PubMed ID: 37690264)
1. Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells.
Loffelmann M; Škrott Z; Majera D; Štarha P; Kryštof V; Mistrík M
Eur J Med Chem; 2023 Dec; 261():115790. PubMed ID: 37690264
[TBL] [Abstract][Full Text] [Related]
2. Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway.
Majera D; Skrott Z; Chroma K; Merchut-Maya JM; Mistrik M; Bartek J
Cells; 2020 Feb; 9(2):. PubMed ID: 32085572
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
Skrott Z; Majera D; Gursky J; Buchtova T; Hajduch M; Mistrik M; Bartek J
Oncogene; 2019 Oct; 38(40):6711-6722. PubMed ID: 31391554
[TBL] [Abstract][Full Text] [Related]
4. Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative.
Pan M; Zheng Q; Yu Y; Ai H; Xie Y; Zeng X; Wang C; Liu L; Zhao M
Nat Commun; 2021 Jan; 12(1):121. PubMed ID: 33402676
[TBL] [Abstract][Full Text] [Related]
5. Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET.
Kanellis DC; Zisi A; Skrott Z; Lemmens B; Espinoza JA; Kosar M; Björkman A; Li X; Arampatzis S; Bartkova J; Andújar-Sánchez M; Fernandez-Capetillo O; Mistrik M; Lindström MS; Bartek J
Cell Death Differ; 2023 Jul; 30(7):1666-1678. PubMed ID: 37142656
[TBL] [Abstract][Full Text] [Related]
6. Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram.
Majera D; Skrott Z; Bouchal J; Bartkova J; Simkova D; Gachechiladze M; Steigerova J; Kurfurstova D; Gursky J; Korinkova G; Cwiertka K; Hodny Z; Mistrik M; Bartek J
Prostate; 2019 Mar; 79(4):352-362. PubMed ID: 30499118
[TBL] [Abstract][Full Text] [Related]
7. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET.
Buchtova T; Skrott Z; Chroma K; Rehulka J; Dzubak P; Hajduch M; Lukac D; Arampatzis S; Bartek J; Mistrik M
Mol Oncol; 2022 Apr; 16(7):1541-1554. PubMed ID: 34632694
[TBL] [Abstract][Full Text] [Related]
9. Comparison of force fields to study the zinc-finger containing protein NPL4, a target for disulfiram in cancer therapy.
Scrima S; Tiberti M; Ryde U; Lambrughi M; Papaleo E
Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140921. PubMed ID: 37230374
[TBL] [Abstract][Full Text] [Related]
10. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
Skrott Z; Mistrik M; Andersen KK; Friis S; Majera D; Gursky J; Ozdian T; Bartkova J; Turi Z; Moudry P; Kraus M; Michalova M; Vaclavkova J; Dzubak P; Vrobel I; Pouckova P; Sedlacek J; Miklovicova A; Kutt A; Li J; Mattova J; Driessen C; Dou QP; Olsen J; Hajduch M; Cvek B; Deshaies RJ; Bartek J
Nature; 2017 Dec; 552(7684):194-199. PubMed ID: 29211715
[TBL] [Abstract][Full Text] [Related]
11. Nanoscale Copper(II)-Diethyldithiocarbamate Coordination Polymer as a Drug Self-Delivery System for Highly Robust and Specific Cancer Therapy.
Peng Y; Liu P; Meng Y; Hu S; Ding J; Zhou W
Mol Pharm; 2020 Aug; 17(8):2864-2873. PubMed ID: 32551674
[TBL] [Abstract][Full Text] [Related]
12. Dual Action of Acidic Microenvironment on the Enrichment of the Active Metabolite of Disulfiram in Tumor Tissues.
Tang C; Pang X; Guo Z; Guo R; Liu L; Chen X
Drug Metab Dispos; 2021 Jun; 49(6):434-441. PubMed ID: 33762296
[TBL] [Abstract][Full Text] [Related]
13. Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram/copper-induced oxidative stress and ferroptosis in renal cell carcinoma.
Ni X; Ye C; Yu X; Zhang Y; Hou Y; Zheng Q; Chen Z; Wang L; Weng X; Yang C; Liu X
Eur J Pharmacol; 2023 Dec; 960():176110. PubMed ID: 37838104
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways.
Liu Y; Guan X; Wang M; Wang N; Chen Y; Li B; Xu Z; Fu F; Zheng Z; Du C
Bioengineered; 2022 Mar; 13(3):6579-6589. PubMed ID: 35290151
[TBL] [Abstract][Full Text] [Related]
15. The comparative effects of diethyldithiocarbamate-copper complex with established proteasome inhibitors on expression levels of CYP1A2/3A4 and their master regulators, aryl hydrocarbon and pregnane X receptor in primary cultures of human hepatocytes.
Vrzal R; Dvorak Z
Fundam Clin Pharmacol; 2016 Dec; 30(6):585-595. PubMed ID: 27414036
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of disulfiram in T-cell malignancies through NPL4-mediated ubiquitin-proteasome pathway.
Chen C; Nie D; Huang Y; Yu X; Chen Z; Zhong M; Liu X; Wang X; Sui S; Liu Z; Tan J; Yu Z; Li Y; Zeng C
J Leukoc Biol; 2022 Oct; 112(4):919-929. PubMed ID: 35363385
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
[TBL] [Abstract][Full Text] [Related]
18. Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model.
Serra R; Zhao T; Huq S; Gorelick NL; Casaos J; Cecia A; Mangraviti A; Eberhart C; Bai R; Olivi A; Brem H; Jackson EM; Tyler B
PLoS One; 2021; 16(11):e0251957. PubMed ID: 34731160
[TBL] [Abstract][Full Text] [Related]
19. Copper(II)-disulfiram loaded melanin-dots for cancer theranostics.
Shi H; Suo Y; Zhang Z; Liu R; Liu H; Cheng Z
Nanomedicine; 2021 Feb; 32():102340. PubMed ID: 33227540
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the p97-Ufd1-Npl4 complex.
Pye VE; Beuron F; Keetch CA; McKeown C; Robinson CV; Meyer HH; Zhang X; Freemont PS
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):467-72. PubMed ID: 17202270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
